TCL Archive NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions. March 12, 2010
TCL Archive ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer October 9, 2009
TCL Archive NCI Considers Seeking New Study Section For Clinical Research, Or Expansion Of E2 November 23, 1990